Juan M. Lavista Ferres
CVP and Chief Data Scientist at Microsoft
Published Mar 11, 2025
Proteins are the tiny machines that power life, from helping us fight infections to breaking down food for energy. But many proteins don’t work alone, they come together in complex structures called homo-oligomers. Understanding how they assemble is key to unlocking breakthroughs in medicine, biotechnology, and disease research. Until now, predicting these structures has been slow and difficult, relying on time-consuming experiments or computational methods that require significant resources
That’s where Seq2Symm comes in. Developed and led by Meghana Kshirsagar from Microsoft’s AI for Good Lab in collaboration with Nobel Prize winner David Baker, Seoul National University Professor Minkyung Baek , MIT Professor Bonnie Berger, and University of Pennsylvania Professor Gregory Bowman. This new AI model based on ESM2 can predict protein structures faster and more accurately than ever before—analyzing 80,000 proteins per hour. This is a major leap forward, allowing researchers to study millions of proteins in ways never before possible. By providing rapid and reliable insights into how proteins assemble, Seq2Symm opens the door to major scientific advancements across multiple fields. That means understanding diseases better, getting to medical breakthroughs faster, and empowering researchers to tackle bigger problems that impact all of us.
Leveraging AI to solve the world's greatest challenges is something we are deeply committed to as a company. This commitment is shared by many of our partners, including the researchers at the Baker Lab at the University of Washington, who have been invaluable collaborators for more than three years.
Why This Matters
- Faster Drug Discovery: Understanding protein structures helps scientists design better medicines by targeting the right proteins more effectively, reducing the time and cost of developing new treatments.
- Better Disease Research: Many diseases, including Alzheimer’s and certain cancers, are linked to protein malfunctions involving homo-oligomers. With Seq2Symm, researchers can quickly identify structural abnormalities that contribute to these conditions and explore potential treatments.
- Advancements in Synthetic Biology: Scientists can use AI-powered predictions to design new proteins with specific functions, leading to breakthroughs in medicine, bioengineering, and sustainable materials such as biodegradable polymers that are made up of homo-oligomers.
- Stronger Viral Research: Many viruses, including COVID-19, rely on symmetrical homo-oligomeric protein structures to replicate. Understanding these structures can help scientists develop more effective antiviral drugs and vaccines.
This technology is open-source, giving researchers worldwide access to a tool that dramatically accelerates discoveries. By making protein structure prediction faster, more scalable, and more accurate, Seq2Symm is helping scientists unlock the mysteries of life at an unprecedented pace.
While we are immensely proud of the progress, we recognize there is more work to be done. The challenges we are tracking are complex and ever evolving, requiring continuous attention and ongoing innovation. We are grateful to our partners that share our values and dedication to continuing the work and will continue to collaborate with the Baker Lab at the University of Washington, to ensure the continued success of this model.
More articles by Juan M. Lavista Ferres
-
What 40 Million Devices Can Teach Us About Digital Literacy in America
Feb 15, 2025
What 40 Million Devices Can Teach Us About Digital Literacy in America
Every week, I teach computer science to a group of elementary school students. Watching them learn to code, create, and…
-
Understanding why do People engage with Unreliable Websites
Oct 30, 2024
Understanding why do People engage with Unreliable Websites
In today’s digital landscape, the spread of misinformation is a growing concern. Many discussions have centered around…
-
Remarks by Juan Lavista Ferres at the United Nations General Assembly's Summit of the Future
Sep 25, 2024
Remarks by Juan Lavista Ferres at the United Nations General Assembly's Summit of the Future
Statement by Dr. Juan Lavista Ferres Corporate Vice President and Chief Data Scientist, Microsoft 23 September 2024…
-
AI for Good: Applications in Sustainability, Humanitarian Action, and Health
Apr 2, 2024
AI for Good: Applications in Sustainability, Humanitarian Action, and Health
In the past six years, as head of the AI for Good Labs at Microsoft, I've had the extraordinary privilege of working on…
-
Quitbot: Using AI to help fight addiction.
Feb 28, 2024
Quitbot: Using AI to help fight addiction.
By Juan M. Lavista Ferres, Microsoft Chief Data Scientist and Lab director of the Microsoft AI for Good Lab After years…
-
Transforming Breast Cancer Detection with AI
Dec 20, 2023
Transforming Breast Cancer Detection with AI
The stark reality that one in eight women in the United States will develop breast cancer in their lifetime underscores…
-
A World Seen in Full is a Better World
Dec 1, 2023
A World Seen in Full is a Better World
When news of the earthquakes in Afghanistan broke in October 2023, Microsoft AI for Good Lab mobilized to support first…
-
The Promise of AI for Non-Native English Speakers
Oct 12, 2023
The Promise of AI for Non-Native English Speakers
As we wrap up Hispanic Heritage month, I’ve been reflecting on what it means to be Hispanic and working in America and…
-
Using AI to advance the Early Warnings for All Initiative
Sep 20, 2023
Using AI to advance the Early Warnings for All Initiative
With the increasing strength and frequency of extreme weather events, it’s becoming more and more crucial for all…
-
Using AI to protect the Amazon
Sep 7, 2023
Using AI to protect the Amazon
The Amazon rainforest in South America is one of the world’s largest and most dense, but it is disappearing at an…